[{"id":"483965a6-ed6b-4cce-b166-abbe6a657118","acronym":"","url":"https://clinicaltrials.gov/study/NCT05706129","created_at":"2023-05-15T15:04:33.169Z","updated_at":"2024-07-02T16:35:12.345Z","phase":"Phase 1/2","brief_title":"A Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors","source_id_and_acronym":"NCT05706129","lead_sponsor":"Debiopharm International SA","biomarkers":" EGFR","pipe":"","alterations":" ","tags":["EGFR"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e ITM-91"],"overall_status":"Recruiting","enrollment":" Enrollment 155","initiation":"Initiation: 03/14/2023","start_date":" 03/14/2023","primary_txt":" Primary completion: 01/01/2026","primary_completion_date":" 01/01/2026","study_txt":" Completion: 01/01/2027","study_completion_date":" 01/01/2027","last_update_posted":"2024-03-29"}]